載入...
Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer
LESSONS LEARNED. This clinical trial, evaluating the efficacy and safety of a carboplatin plus paclitaxel regimen in a biweekly or weekly schedule instead of the more toxic 3‐weekly administration, showed that the weekly regimen was better in efficacy than the biweekly regimen, with mild toxicities,...
Na minha lista:
| 發表在: | Oncologist |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley & Sons, Inc.
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6853129/ https://ncbi.nlm.nih.gov/pubmed/31332099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0513 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|